Allspring Global Investments Holdings LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 59.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 71,538 shares of the exchange traded fund’s stock after selling 105,474 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in SPDR S&P Biotech ETF were worth $9,196,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Financial Life Planners purchased a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $30,000. SHP Wealth Management purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $32,000.
SPDR S&P Biotech ETF Trading Down 1.5%
SPDR S&P Biotech ETF stock opened at $152.11 on Thursday. SPDR S&P Biotech ETF has a 12 month low of $84.39 and a 12 month high of $165.71. The stock’s 50 day simple moving average is $143.49 and its two-hundred day simple moving average is $133.10. The firm has a market cap of $10.21 billion, a PE ratio of 11.47 and a beta of 0.82.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
